Literature DB >> 26122747

Elevated Expression of CD109 in Esophageal Squamous Cell Carcinoma.

Fengyun Dong1, Fuhong Liu, Suhua Yan, Xiaochun Liu, Zhongmin Jiang, Ju Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26122747     DOI： 10.1007/s12253-014-9894-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  10 in total

1.  Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes.

Authors:  Kenneth W Finnson; Betty Y Y Tam; Kai Liu; Anne Marcoux; Pierre Lepage; Stephane Roy; Albane A Bizet; Anie Philip
Journal:  FASEB J       Date:  2006-06-05       Impact factor: 5.191

2.  Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.

Authors:  Hidenobu Osawa; Masanobu Nakajima; Hiroyuki Kato; Minoru Fukuchi; Hiroyuki Kuwano
Journal:  Anticancer Res       Date:  2004 Nov-Dec       Impact factor: 2.480

3.  CD109 expression in squamous cell carcinoma of the uterine cervix.

Authors:  Jing-Min Zhang; Mizuo Hashimoto; Kumi Kawai; Yoshiki Murakumo; Tomoko Sato; Masatoshi Ichihara; Shigeo Nakamura; Masahide Takahashi
Journal:  Pathol Int       Date:  2005-04       Impact factor: 2.534

4.  Endothelium in hepatic cavernous hemangiomas does not express the hyaluronan receptor for endocytosis.

Authors:  Brian Duff; Janet A Weigel; Patricia Bourne; Paul H Weigel; Carl T McGary
Journal:  Hum Pathol       Date:  2002-03       Impact factor: 3.466

Review 5.  Chemoprevention of esophageal squamous cell carcinoma.

Authors:  Gary D Stoner; Li-Shu Wang; Tong Chen
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-15       Impact factor: 4.219

6.  Expression of CD109 in human cancer.

Authors:  Mizuo Hashimoto; Masatoshi Ichihara; Tsuyoshi Watanabe; Kumi Kawai; Katsumi Koshikawa; Norihiro Yuasa; Takashi Takahashi; Yasushi Yatabe; Yoshiki Murakumo; Jing-Min Zhang; Yuji Nimura; Masahide Takahashi
Journal:  Oncogene       Date:  2004-04-29       Impact factor: 9.867

7.  Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity.

Authors:  Sumitaka Hagiwara; Yoshiki Murakumo; Tomoko Sato; Toshio Shigetomi; Kenji Mitsudo; Iwai Tohnai; Minoru Ueda; Masahide Takahashi
Journal:  Cancer Sci       Date:  2008-10       Impact factor: 6.716

8.  Clinicopathological significance of BMP7 expression in esophageal squamous cell carcinoma.

Authors:  Koichi Megumi; Sumiya Ishigami; Yasuto Uchikado; Yoshiaki Kita; Hiroshi Okumura; Masataka Matsumoto; Yoshikazu Uenosono; Takaaki Arigami; Yuko Kijima; Masaki Kitazono; Hiroyuki Shinchi; Shinichi Ueno; Shoji Natsugoe
Journal:  Ann Surg Oncol       Date:  2011-09-13       Impact factor: 5.344

9.  Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma.

Authors:  Pelin Özün Ozbay; Tekin Ekinci; Seyran Yiǧit; Ali Yavuzcan; Selda Uysal; Ferit Soylu; Fulya Cakalagaoglu
Journal:  Onco Targets Ther       Date:  2013-06-07       Impact factor: 4.147

10.  Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan.

Authors:  Lucia Cuppini; Angelica Calleri; Maria Grazia Bruzzone; Elena Prodi; Elena Anghileri; Serena Pellegatta; Patrizia Mancuso; Paola Porrati; Anna Luisa Di Stefano; Mauro Ceroni; Francesco Bertolini; Gaetano Finocchiaro; Marica Eoli
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240
  10 in total
  8 in total

Review 1.  CD109 and squamous cell carcinoma.

Authors:  Ruixia Qi; Fengyun Dong; Qiang Liu; Yoshiki Murakumo; Ju Liu
Journal:  J Transl Med       Date:  2018-04-06       Impact factor: 5.531

2.  CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX.

Authors:  Wenting Jia; Caiping Ren; Lei Wang; Bin Zhu; Wei Jia; Menghui Gao; Fei Zeng; Liang Zeng; Xiaomeng Xia; Xiaobing Zhang; Ting Fu; Shasha Li; Can Du; Xingjun Jiang; Yuxiang Chen; Weihong Tan; Zilong Zhao; Weidong Liu
Journal:  Oncotarget       Date:  2016-08-23

3.  Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer.

Authors:  Gustavo A Arias-Pinilla; Angus G Dalgleish; Satvinder Mudan; Izhar Bagwan; Anthony J Walker; Helmout Modjtahedi
Journal:  Oncotarget       Date:  2018-04-13

4.  CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.

Authors:  Xue-Tang Mo; Thomas Ho-Yin Leung; Hermit Wai-Man Tang; Michelle Kwan-Yee Siu; Peter Kok-Ting Wan; Karen Kar-Loen Chan; Annie Nga-Yin Cheung; Hextan Yuen-Sheung Ngan
Journal:  Br J Cancer       Date:  2020-06-08       Impact factor: 7.640

5.  CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.

Authors:  Shufeng Zhou; Sabrina Daniela da Silva; Peter M Siegel; Anie Philip
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

6.  CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells.

Authors:  Shufeng Zhou; Amani Hassan; Tenzin Kungyal; Sebastien Tabariès; José Luis Ramírez García Luna; Peter M Siegel; Anie Philip
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

7.  CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder.

Authors:  Fengyun Dong; Chuanfeng Lu; Xiaocui Chen; Yuan Guo; Ju Liu
Journal:  Diagn Pathol       Date:  2015-08-07       Impact factor: 2.644

8.  CD109 expression is upregulated in penile squamous cell carcinoma.

Authors:  Fengyun Dong; Jin Wang; Yinghua Xu; Zuowang Cheng; Xiaocui Chen; Yifan Wang; Ju Liu
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.